Precision, Power, and Speed for the OR
Integra LifeSciences partnered with Suntra MedTech Solutions to accelerate the development of their next-generation ultrasonic tissue ablation system, CUSA® Clarity. The project had a tight timeline and complex engineering requirements, including a need for real-time control over aspiration and irrigation subsystems. The system also had to anticipate mechanical wear while maintaining accuracy critical to surgical outcomes.
Suntra designed and developed the electronics and firmware for a modular control system that delivered both precision and durability. Anticipating degradation of the aspiration pump over time, we engineered the firmware to account for performance drift, ensuring lasting accuracy. The system architecture incorporated modular boards including a Windows Qseven module to support future updates and extend the product lifecycle. All designs were fully compliant with IEC 60601-1 and IEC 60601-2-2 standards for high-frequency surgical safety.
The resulting device gave surgeons more control in delicate procedures, enabling selective tissue ablation while preserving vasculature ultimately reducing surgery times and improving patient outcomes. CUSA® Clarity achieved both CE Mark and FDA 510(k) approval, launched successfully, and exceeded sales expectations, affirming Suntra’s role in delivering complex, high-performance solutions under pressure.
